IQVIA Holdings Inc. is a global leader in clinical research and technology solutions for the life sciences industry. Created in 2016 through the merger of Quintiles and IMS Health, the company brought together clinical trial services with extensive healthcare data and analytics capabilities. Its research and development solutions segment delivers outsourced clinical development services across drug discovery, trial design, patient recruitment, site management, clinical testing, real-world studies, and the regulatory approval process. Its commercial solutions segment helps companies improve product commercialization through analytics, technology, and outsourced sales and medical services. Through these combined offerings, IQVIA supports customers across the life sciences sector, including biopharmaceutical companies, providers, payers, and policymakers.